RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in RedHill Biopharma Ltd. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q2 2023
- Shares held
- 1.53M
- +1.18M (+339.2%) vs. Q2 2023
- Total value
- $781.9K
- +$362.8K (+86.5%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 4
- 5 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $270.0K |
| Q1 2026 | 16 | $386.5K |
| Q4 2025 | 17 | $514.5K |
| Q3 2025 | 14 | $51.2K |
| Q2 2025 | 12 | $37.9K |
| Q1 2025 | 12 | $80.5K |
| Q4 2024 | 11 | $103.5K |
| Q3 2024 | 11 | $48.8K |
| Q2 2024 | 18 | $719.7K |
| Q1 2024 | 17 | $1.40M |
| Q4 2023 | 19 | $449.2K |
| Q3 2023 | 19 | $781.9K |
| Q2 2023 | 21 | $419.2K |
| Q1 2023 | 20 | $1.20M |
| Q4 2022 | 41 | $1.51M |
| Q3 2022 | 43 | $1.46M |
| Q2 2022 | 48 | $3.89M |
| Q1 2022 | 49 | $11.9M |
| Q4 2021 | 57 | $12.5M |
| Q3 2021 | 61 | $24.5M |
| Q2 2021 | 55 | $49.1M |
| Q1 2021 | 64 | $77.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 8 | $4 | 0.00% | −69−89.6% | Reduced |
| IFP Advisors, Inc | 7 | $4 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 23 | $12 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 32 | $16 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 71 | $36 | 0.00% | −503−87.6% | Reduced |
| Advisor Group Holdings, Inc. | 114 | $58 | 0.00% | −2−1.7% | Reduced |
| Steward Partners Investment Advisory, LLC | 125 | $64 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 401 | $205 | 0.00% | −200−33.3% | Reduced |
| Group One Trading, L.P. | 615 | $314 | 0.00% | −14−2.2% | Reduced |
| Royal Bank of Canada | 2,246 | $1.00K | 0.00% | +2,104+1,481.7% | Added |
| Rhumbline Advisers | 3,014 | $1.54K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,402 | $2.25K | 0.00% | 00.0% | Unchanged |
| We Are One Seven, LLC | 15,750 | $8.03K | 0.00% | +5,000+46.5% | Added |
| Virtu Financial LLC | 19,865 | $10.0K | 0.00% | +9,137+85.2% | Added |
| Two Sigma Securities, LLC | 25,382 | $12.9K | 0.00% | +12,233+93.0% | Added |
| Gagnon Securities LLC | 47,965 | $24.5K | 0.01% | +47,965 | New |
| Citadel Advisors LLC | 55,779 | $28.4K | 0.00% | +40,050+254.6% | Added |
| Sabby Management, LLC | 635,006 | $323.9K | 1.02% | +635,006 | New |
| Armistice Capital, LLC | 722,894 | $368.7K | 0.01% | +722,894 | New |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −288,000−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,075−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BDO Wealth Advisors, LLC | – | – | – | – | Not filed |